That structural abnormalities may be responsible for nonamyloid immunoglobulin (Ig) light chain deposition disease (LCDD) is suggested by previous results of Ig biosynthesis studies, but this hypothesis was not documented at the molecular level. We report on the first complete primary sequence deduced from cDNA analysis of a K light chain responsible for LCDD associated with an apparently nonsecretory myeloma.
Introduction
Two diseases featuring tissue deposition of monoclonal immunoglobulin (Ig)-related material, AL-type amyloidosis, and light chain (LC)1 deposition disease (LCDD), are severe complications of either overtly malignant, mostly multiple my-eloma, or apparently benign ("primary" forms) plasma cell dyscrasias (1) (2) (3) (4) (5) (6) . A large body of information has been collected in amyloidosis concerning the nature of the deposited material, serum and urinary Ig, and Ig biosynthesis (1, (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . In contrast, data comparing the amino acid sequences of Ig produced by the monoclonal plasma cells with the deposited protein are not yet available in LCDD (5) . In a recently published LCDD case, the same 14 NH2-terminal VKI subgroup amino acid sequence was found in a deposited K chain and its fragments having relative molecular masses (Mr) of 28,000, 20,000, 16,000, and 15,000 (24) . That structural abnormalities of monoclonal Ig may play a pathogenetic role in LCDD is suggested by recurrence of the disease in grafted kidney (25) and by results ofin vitro Ig biosynthesis experiments and study of serum monoclonal Ig. In some, but not all patients, the plasma cells produced LC with an abnormal size (either short or apparently large) that were glycosylated and polymerized in vitro and in vivo; when a heavy chain was also present in tissue deposits, it was found to be truncated and there was a correlation between the occurrence of structural abnormalities of Ig chains and their finding in the deposits by immunofluorescence (3, 4, (26) (27) (28) . In such cases, the abnormal Ig chains were usually not detectable in significant amounts in serum and urine, some patients being affected with so-called nonsecretory myeloma. The occurrence ofLCDD and amyloidosis in nonsecretory myeloma is not surprising because plasma cells from several nonsecretory myeloma patients were found to produce and secrete abnormal Ig chains which were undetectable in the serum and urine, probably due to rapid postsecretory degradation and/or tissue deposition (3, 4, 23, (26) (27) (28) (29) . We herein report on a patient with nonsecretory myeloma and K LCDD in whom we sequenced the monoclonal LC at the complementary DNA (cDNA) level and showed the deposited LC to have the same NH2-terminal sequence. The plasma cell K chain was N-glycosylated due to a mutation in the variable (V) (30) was repeatedly negative. Pathological and immunofluorescent study ofan open renal biopsy showed nodular glomerulosclero-sis and K chain deposits in the mesangium, glomerular capillaries, tubular basement membranes, and arterial walls. The deposited material was strongly stained by the periodic acid-Schiff (PAS) reaction. Congo red and thioflavine T staining were negative. Electron microscopic study revealed dense granular deposits without fibrillar organization. Skeletal x-ray survey showed diffuse osteoporosis without lytic lesions. Bone marrow smears contained 10% plasma cells. The bone marrow biopsy pattern was diagnostic of myeloma. Cytoplasmic immunofluorescence of bone marrow cells collected by aspiration before treatment also showed 10% plasma cells which stained for K light chains and were negative with anti-X, --y, -a, -1i, and -6 conjugates.
Study ofthe kidney K chains. The same open biopsy specimen (-50 mg) was used for immunohistochemical, ultrastructural, and biochemical studies. The fragment used for protein study was ground in liquid nitrogen, washed with cold 10 mM PBS, pH 7.4, containing 1 mM PMSF and 5 mM E-aminocaproic acid, and centrifuged at 110,000 gat 4VC for 10 mn. After a second identical washing, the pellet was resuspended in 50 Ml of 1% SDS, 10% glycerol, 1% 2-mercaptoethanol, 62.5 mM Tris/HCl, pH 6.8, buffer (sample buffer). This extract was incubated 10 mn at 70'C and analysed by SDS-12% PAGE (31) followed by electroblotting on nitrocellulose sheets. After saturation with 5% skimmed milk, 0.5% Tween 20, the nitrocellulose was incubated with alkaline phosphatase-conjugated anti-K antibody (Sigma Chemical Co., St. Louis, MO) and revealed with 0.4 mM tetrazolium nitroblue/ bromochloroindolyl phosphate. A similar SDS-PAGE gel containing 10 mM reduced glutathione was transferred onto an Immobilon-P membrane (Millipore, Bedford, MA) according to Matsudaira (32) and stained with Coomassie blue. The band corresponding to K chains was determined by comparison with an adjacent lane revealed by the anti-K conjugate, cut out, and used for the determination ofthe NH2-terminal amino acid sequence on a gas-liquid solid phase sequencer (470A; Applied Biosystems, Inc., Foster City, CA) (33, 34) . The latter analysis was performed by Dr. Denoroy at the Service Central d'Analyse, CNRS (Vernaison, France), without knowledge of the cDNA sequence data.
Nucleic acid studies. Cells from the patient's bone marrow obtained at presentation were washed three times with sterile PBS. Total RNA was prepared by lysis of the cells in 4 M guanidine isothiocyanate followed by centrifugation at 170,000 g during 18 h through a 5.7 M cesium chloride pad (35) . Total RNA was analyzed on 1% agarose, 0.7 M formaldehyde gels in comparison with the normal-sized K mRNA from the Burkitt's lymphoma cell line JI (36), transferred to nylon sheets and hybridized with appropriate DNA probes. The CK probe was a 2.5-kb Eco RI genomic fiagment containing the human CK exon; the JK probe was a 1.9-kb Sac I genomic fragment encompassing all five JK segments; the CX probe was a 3.5-kb Eco RI-Hind III fragment containing the CX2 gene; the C-y probe was a 1.5-kb Pst I fragment containing the hinge, CH2 and CH3 exons ofthe C'yl gene. A (Fig. 3) . Trace amounts of norchains also incorpo mal sized K chains were also detected in the extract, as well as in precipitated by the; the washing supernatants (not shown). Although the deposited a significant amoui K chain represented apparently < 1% of the proteins fractionated by SDS-PAGE, the 13 NH2-terminal aminoacids could be sequenced. This sequence was identical to residues determined by codons + 1 to + 13 of the cDNA (Fig. 2) . Study of biosynthetically labeled Ig produced by bone marrow cells is shown on Fig. 4 ey deposited K chain was detectable in both ts and culture supernatants (Fig. 4 , lanes a Lrrow cells labeled with 3H-leucine, together :5,000 likely corresponding to K chains from rhe abnormally large K chain was reduced to treatment with N-glycosidase F (Fig. 4 , lanes enlarged K chain was detectable among proLcorporation of 14C-glucose (Fig. 4 , lanes e vith Mr corresponding to y, a, and ,u heavy rated 3H-leu and 14C-glucose and were coanti-K antibody, confirming the presence of nt of polyclonal B cells. A control experi- ment with the IgA lK producing cell line IARC3 17 showed that, under the same conditions, the a1 heavy chain was also deglycosylated after N-glycosidase F treatment as expected, whereas the migration of the unglycosylated normal sized K chains was unchanged (Fig. 4, lanes g and h) . SDS-PAGE analysis ofunreduced anti-K precipitates showed that the patient's K chain was mainly present in monomeric and dimeric forms in both cytoplasmic extracts and cell supernatants (not shown).
Discussion
The present patient presented with typical K LCDD, and "nonsecretory" myeloma. K chains deposited in the studied kidney biopsy specimen were not significantly degraded, because virtually only a single band of the same abnormally high relative molecular mass as that of K chains produced by bone marrow plasma cells was found on SDS-PAGE. Such an elevated apparent mass had been already demonstrated in other cases at the proliferative plasma cell level by biosynthetic labeling experiments (3, 4, (26) (27) (28) . In addition to their similarly high relative molecular mass, identity between the deposited K chain and that produced by the proliferating plasma cells was confirmed by the sequence of the myeloma cells K mRNA and of the 13 NH2-terminal amino acids of the kidney LC. The K mRNA from the monoclonal bone marrow cells had a normal size by Northern blotting and sequencing and an overall normal structure. However, the V segment showed several peculiarities. It can be undoubtedly assigned to the VKIV subgroup. This subgroup is encoded by a single germline V gene (38) and accounts for -8% of monoclonal K chains (21) . Several point mutations were found which could modify the conformation of the V domain. Four substitutions were observed in the complementarity determining region (CDR)1 at positions +27, +27C, +27D, and +27F. Two substitutions in the CDR3 included replacement ofproline +95 by a leucine. Thus, both the CDR1 and CDR3 regions did not fit with any of the canonical structures defined for K hypervariable regions (40) . In particular, the presence of a proline residue at position +94 or +95 has been considered as being mainly responsible for the conformation of the third hypervariable region (41) . Two substitutions were also identified in the framework (FR)3 region: Asp --Asn (+70) and Ser -> Arg (+77), the former determining a potential N-glycosylation site at position +70. LC V regions of the VKjV subgroup have been entirely sequenced in five monoclonal Ig (42, 43) ; in none of these cases was a N-glycosylation site present. Evidence for glycosylation of the patient's K chain was obtained from results ofbiosynthetic labeling with 14C-glucose. In addition, the abnormal size ofthe K chains internally labeled with 3H-leucine shifted to normal after treatment with N-glycosidase F. This is in agreement with the strong PAS-positivity of the renal deposits. Glycosylated K chains were found both in cytoplasmic extracts and cell supernatants, thus showing that N-glycosylation occurred in the bone marrow plasma cells, in agreement with our previous results in other patients. The single published LCDD K chain of which the NH2-terminal residues were sequenced belonged to the VKI subgroup (24) , that is expressed in 56% of monoclonal K chains (21) . This K chain, which was present in the deposits together with fragments, had Mr 28,000, which might relate to glycosylation also.
LCDD and AL amyloidosis are closely related diseases which may be associated in the same patient (4) (5) (6) (44) (45) (46) . It may be of interest that glycosylated LC were found in amyloid deposits (9, 11, 12) . This is reminiscent of our previous finding in biosynthesis experiments of evidence suggestive ofLC glycosylation, a relatively rare event in plasma cell proliferations (47) , in every LCDD case with short or apparently enlarged LC (two-thirds of the studied cases, whereas in the other cases, monoclonal LC had a normal size without any data suggestive of glycosylation). We have also previously studied in more detail enlarged K chains obtained from the serum from two patients with LCDD. These LC were found to contain 10.7 and 14.7% carbohydrates, respectively, with a composition compatible with N-glycosylation (4, 28) . These LC were found to polymerize in vivo and in vitro by covalent and noncovalent bridges, possibly involving the presence of carbohydrates. Whether such a possible mechanism of LC polymerization might be involved in tissue deposition remains an open question. The present patient's K chain was secreted mainly as monomer and dimer, and its sequence revealed no extra cysteine residue that could be used in disulfide bonds. Thus, glycosylation in itself might play a direct role in tissue precipitation because of binding to collagen and decreased catabolism ofthe light chains, as documented in a different situation, i.e., diabetes (48, 49) . Such a hypothesis would explain the striking similarities between the glomerular lesions of LCDD and of diabetic nephropathy. As already mentioned, LC glycosylation is not a constant feature in LCDD. In the present patient, the unusual amino acid substitutions observed in the VK region might modify its folding and conformation and favor tissue deposition. Computer simulation did not favor this hypothesis, but the limitations ofthis approach are well known. In any case and whatever the precise mechanism ofdeposition, the present observation documents a long-suggested but never-proven concept, i.e., that the basic pathogenetic abnormality in LCDD is at the LC level.
